Has Timothy Omara, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,008 in general payments to Timothy Omara, MD across 47 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Timothy Omara, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Timothy Omara, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Timothy Omara, MD

Adult Reconstructive Orthopaedic Surgery · Reno, NVNPI 1386787984

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,314 of the $8,008 with a category attached, or 66.4%. Smith+Nephew accounts for 82.5% of it on its own, with 6 other manufacturers making up the rest.

$8,008in general payments, 2019–2025

Across 47 payments — averaging $170.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$7K
Stryker$1K
Acumed LLC$125
Orthofix Medical, Inc.$64
Baudax Bio Inc.$28
Davol Inc.$27
plus $15 from 1 others

What the payments were for

Travel & lodging$5,31466%
Food & beverage$2,69434%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	31	$6,608
Stryker	9	$1,141
Acumed LLC	1	$125
Orthofix Medical, Inc.	2	$64
Baudax Bio Inc.	2	$28
Davol Inc.	1	$27
Musculoskeletal Transplant Foundation Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$267,480

Medicare patients

442

Services billed

1,991

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	156	$827
Meloxicam	141	$266
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	14	$92
Tramadol Hcl	34	$85
Amoxicillin	11	$51

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Reno

Michael RiesReno$7.7M
Chad WattsReno$78K
Jackson JonesReno$37K
Shay WarrenReno$23K
Kingsley OladejiReno$21K
Sanjai ShuklaReno$21K
Eric BoydenReno$7K
Steven NishiyamaLas Vegas$836K
Parminder KangLas Vegas$26K
Justin LimtongLas Vegas$22K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →